An Innovative Biotech Company
CSTEAM Biotechnology: Driving Innovation in Life Sciences
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
CSTEAM Biotechnology, headquartered in Ohio, USA, is a pioneering company dedicated to driving the development of innovative biotechnology products. Our product development focuses on four core areas: (1) Antibodies, (2) Biochips, (3) Biological models, and (4) Gene and Cell Therapies.
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
Our mission is to revolutionize the treatment of difficult diseases through breakthrough gene and cell therapies, improve the accuracy of disease diagnosis through cutting-edge biochip technology, and provide valuable scientific experimental resources for scientific research, including advanced biological models and engineered antibodies developed through state-of-the-art gene editing and antibody engineering technologies.
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
At CSTEAM Biotechnology, collaboration is at the core of our success. We actively establish strategic partnerships with universities, research institutions, hospitals, and pharmaceutical companies. Through these alliances, we aim to accelerate the creation of revolutionary biotechnology solutions to have a meaningful impact on healthcare and benefit people around the world.
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
Antibodies, Biochips, Biological models, and Gene and Cell Therapies
Products and Services
Antibodies
-
Monoclonal antibodies are specific proteins from a single B cell clone, used in diagnostics and therapies for their precision.
-
Polyclonal antibodies, produced by various B cell clones, recognize multiple epitopes, enhancing adaptability and binding strength, beneficial in research and diagnostics.
-
Genetically engineered antibodies, including chimeric, humanized, and fully human types, are created using recombinant DNA technology, offering enhanced effectiveness, stability, and reduced immunogenicity for therapeutic and diagnostic applications.
Biochips
-
Solid biochips, such as DNA and protein microarrays, cellular and tissue microarrays, electrochemical, and optical biochips, analyze genetic variations, protein interactions, cell behavior, and tissue samples, useful in genomics, proteomics, cancer research, diagnostics, and biosensing.
-
Liquid biochips, including lab-on-a-chip, droplet-based microfluidics, paper-based microfluidic devices, and hydrogel-based biochips, facilitate biochemical reactions in liquid environments, aiding point-of-care diagnostics, single-cell analysis, field diagnostics, and tissue engineering.
-
These advancements enhance biomedical research, diagnostics, and personalized medicine.
Biological Models
-
Cellular models, including primary cells and immortalized cell lines, facilitate studies on gene function and drug screening.
-
Organoid models, derived from stem cells, replicate organ structure and function, advancing insights into development, disease mechanisms, and personalized medicine.
-
Animal models, such as mice and zebrafish, provide whole-organism perspectives on genetics, physiology, and pathology.
-
These models are essential for understanding biological processes, developing treatments, and evaluating drug safety and efficacy, bridging the gap between in vitro studies and clinical applications.
Gene and Cell Therapies
-
Gene therapy modifies or introduces genes to correct genetic defects or enhance cell functions, used in treatments for inherited disorders like cystic fibrosis and making cells HIV-resistant.
-
Cell therapy involves administering living cells to restore function or combat diseases, including stem cell transplants for blood disorders and CAR T-cell therapy for cancer.
-
These therapies leverage cutting-edge technology to offer new solutions for previously untreatable conditions, advancing personalized medicine by tailoring treatments to individual patient needs.